Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults. [electronic resource]
Producer: 20111207Description: 1737-45 p. digitalISSN:- 1473-5571
- Adult
- Anti-HIV Agents -- adverse effects
- Area Under Curve
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Heterocyclic Compounds, 3-Ring -- adverse effects
- Humans
- Male
- Middle Aged
- Oxazines
- Piperazines
- Pyridones
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.